Plastone Oy   Report issue

For profit Phase 4
Founded: Konnevesi Finland (1980)
Status: No NME R&D (1980)

Organization Overview

First Clinical Trial
2004
NCT00638677
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2004

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

bifidobacterium animalis (1 trial)

xylitol (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 4)

Dental Caries (Phase 4)

Infections (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2